Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q2 2026 | ~2026-06-30 | $0.0625 |
| Q1 2026 | ~2026-03-31 | $0.0625 |
| Q4 2025 | ~2025-12-30 | $0.0625 |
| Q3 2025 | ~2025-09-30 | $0.0625 |
| Q2 2025 | ~2025-06-30 | $0.0625 |
| Q1 2025 | ~2025-03-31 | $0.0625 |
| Q4 2024 | ~2024-12-30 | $0.0625 |
| Q3 2024 | ~2024-09-30 | $0.0625 |
| Q2 2024 | ~2024-06-30 | $0.0625 |
| Q1 2024 | ~2024-03-31 | $0.0625 |
| Q4 2023 | ~2023-12-30 | $0.0625 |
| Q3 2023 | ~2023-09-30 | $0.0625 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Loews Corporation is a diversified holding company with four principal business segments. Through its subsidiary CNA Financial Corporation, Loews operates one of the largest… commercial property and casualty insurance companies in the United States, offering insurance products including workers' compensation, commercial general liability, commercial auto, surety, medical professional liability, and other specialty insurance lines. The company holds a majority interest in Boardwalk Pipeline Partners, LP, which owns and operates natural gas transportation pipelines in North America. Loews Hotels & Co, a wholly-owned subsidiary, operates a collection of luxury and upscale hotels. Additionally, the company maintains a significant investment portfolio of cash equivalents, fixed maturity securities, equity securities, partnership interests, and other investments. The company's diversified portfolio of businesses and investments is designed to generate long-term shareholder value.
- Name
- Loews Corporation
- Sector
- Financial Services
- Industry
- Insurance - Property & Casualty
- CEO
- Benjamin J. Tisch · President and Chief Executive Officer
- Employees
- —
- IPO Date
- 2017-09-14
- Phone
- 212-521-2000
- Address
- 9 West 57th Street, New York, NY 10019-2714
- Website
- www.loews.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Jane J. Wang | — | — |
| Kenneth I. Siegel | — | — |
| Richard W. Scott | — | — |
| James S. Tisch | Chairman of the Board and Retired President and Chief Executive Officer | — |
| Benjamin J. Tisch | President and Chief Executive Officer | — |
Latest News
- 2026-04-14
- 2026-02-10
- 2026-02-09
-
2026-02-08
Wall Street Week Ahead seekingalpha.com
- 2026-01-22
- 2026-01-20
-
2026-01-09
Mesoblast reports $US35.1m in gross revenue from sales of its cell therapy Ryoncil proactiveinvestors.com
- 2025-12-11